In an interview with Science Friday, Dr. Carl June, one of the pioneers of CAR-T cell therapy and a professor of immunotherapy and director of the Center for Cellular Immunotherapies at the University of Pennsylvania, discusses CAR-T’s continued use in battling new blood cancers, as well as its future potential for treating solid state cancers and autoimmune diseases.
First developed at Penn over a decade ago to treat acute lymphoblastic leukemia, CAR-T continues to successfully treat new types of blood cancers. Researchers are also working on applying the technology to solid state cancers like those of the pancreas and brain, and scientists are at the early stages of testing CAR-T cells to treat autoimmune diseases like multiple sclerosis (MS) and lupus.
Listen to June discuss these new applications of CAR-T in the interview here.
